Location History:
- Osaka, JP (1988)
- Mishima, JP (1988)
- Kyoto, JP (1995 - 2011)
Company Filing History:
3 out of 439 
2 out of 343 
1 out of 1 Years Active: 1988-2011
Title: Kyoichi Ogura: Innovator in ACE Inhibitory Peptides
Introduction
Kyoichi Ogura is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of angiotensin-converting enzyme (ACE) inhibitory peptides. With a total of five patents to his name, Ogura's work has implications for health and medicine.
Latest Patents
Ogura's latest patents focus on ACE inhibitory tripeptides that are resistant to digestion by enzymes after oral intake. This characteristic allows them to maintain their ACE inhibitory activity in vivo. Specifically, he has discovered three tripeptides with demonstrated ACE inhibitory activity and hypotensive effects in animal experiments. These tripeptides have the following amino acid sequences: Leu-Ser-Ala, Val-Ile-Tyr, and Leu-Val-Tyr. Each of these sequences exhibits significant angiotensin-converting enzyme inhibitory activity.
Career Highlights
Throughout his career, Kyoichi Ogura has worked with prominent companies such as Suntory Limited and Suntory Holdings Limited. His experience in these organizations has contributed to his expertise in the field of biochemistry and innovation.
Collaborations
Ogura has collaborated with notable colleagues, including Sumio Asami and Taeko Iino. These partnerships have likely enriched his research and development efforts.
Conclusion
Kyoichi Ogura's innovative work in ACE inhibitory peptides showcases his dedication to advancing medical science. His contributions have the potential to impact health treatments significantly.